Literature DB >> 19285407

Clinicopathologic correlates of giant pituitary adenomas.

Geeta Chacko1, Ari George Chacko, Matilde Lombardero, Sunithi Mani, M S Seshadri, Kalman Kovacs, Bernd W Scheithauer.   

Abstract

Giant adenomas comprise a clinical/therapeutic subset of pituitary adenomas that pose a surgical challenge. The study population consisted of 28 patients who had giant pituitary adenomas, which are defined as tumors with a diameter greater than 5cm. Clinically, five tumors (18%) were endocrinologically functional and 23 (82%) were not. During surgery, one tumor was radically excised, four were subtotally excised, 12 were partially excised, and 11 were biopsied. All of the tumors showed typical histological features of pituitary adenoma. Of the 23 clinically non-functional adenomas, 18 were gonadotrophic tumors, four were null cell adenomas and one was a silent corticotroph adenoma. The MIB-1 labeling indices ranged from 0.1% to 2.0%. The mean topoisomerase labeling index was 0.75%. Microvessel density ranged from 0.42% to 5.55%, and there was moderately intense immunostaining for vascular endothelial growth factor. The present study found giant adenomas to be invasive but slow growing, histologically benign and often gonadotrophic in subtype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285407     DOI: 10.1016/j.jocn.2008.08.018

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  8 in total

1.  The current role of transcranial surgery in the management of pituitary adenomas.

Authors:  Ravindran Pratheesh; Simon Rajaratnam; Krishna Prabhu; Sunithi E Mani; Geeta Chacko; Ari G Chacko
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

2.  Pediatric giant pituitary adenomas: are they different from adults? A clinical analysis of a series of 12 patients.

Authors:  Sumit Sinha; Avijit Sarkari; A K Mahapatra; B S Sharma
Journal:  Childs Nerv Syst       Date:  2014-04-29       Impact factor: 1.475

3.  Correlation between histological subtypes and MRI findings in clinically nonfunctioning pituitary adenomas.

Authors:  Hiroshi Nishioka; Naoko Inoshita; Toshiaki Sano; Noriaki Fukuhara; Shozo Yamada
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

4.  Three-dimensional volumetric measurements in defining endoscope-guided giant adenoma surgery outcomes.

Authors:  Muhammad Omar Chohan; Ariana M Levin; Ranjodh Singh; Zhiping Zhou; Carlos L Green; Jacob J Kazam; Apostolos J Tsiouris; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2016-06       Impact factor: 4.107

5.  Combined simultaneous transcranial and transsphenoidal resection of large-to-giant pituitary adenomas.

Authors:  Gilberto Ka Kit Leung; Hing Yu Law; Kwun Ngai Hung; Yiu Wah Fan; Wai Man Lui
Journal:  Acta Neurochir (Wien)       Date:  2011-04-30       Impact factor: 2.216

Review 6.  Pituitary gland imaging.

Authors:  Simon Rajaratnam
Journal:  Indian J Endocrinol Metab       Date:  2013-10

7.  Analysis of operative efficacy for giant pituitary adenoma.

Authors:  Shousen Wang; Shun'an Lin; Liangfeng Wei; Lin Zhao; Yinxing Huang
Journal:  BMC Surg       Date:  2014-08-28       Impact factor: 2.102

8.  The Role of Endoscopic Endonasal Approach in the Multimodal Management of Giant Pituitary Adenoma: Case Report and Literature Review.

Authors:  Salvatore Chibbaro; Mario Ganau; Arthur Gubian; Antonino Scibilia; Julien Todeschi; Sophie Riehm; Sebastien Moliere; Christian Debry; Bernard Goichot; Francois Proust; Helene Cebula
Journal:  Asian J Neurosurg       Date:  2018 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.